Nonoperating Income (Expense) of MARIZYME, INC. from 30 Jun 2010 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
MARIZYME, INC. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Jun 2010 to 30 Sep 2024.
  • MARIZYME, INC. Nonoperating Income (Expense) for the quarter ending 30 Sep 2024 was $604,831, a 97% increase year-over-year.
  • MARIZYME, INC. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2024 was $7,462,721.
  • MARIZYME, INC. annual Nonoperating Income (Expense) for 2023 was $35,452,820, a 4110% decline from 2022.
  • MARIZYME, INC. annual Nonoperating Income (Expense) for 2022 was $842,074, a 61% increase from 2021.
  • MARIZYME, INC. annual Nonoperating Income (Expense) for 2021 was $2,176,546, a 4689% decline from 2020.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

MARIZYME, INC. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $7,462,721 $604,831 +$21,084,647 +97% 01 Jul 2024 30 Sep 2024 10-Q 05 Mar 2025 2024 Q3
Q2 2024 $13,621,926 $5,846,466 +$25,433,591 +81% 01 Apr 2024 30 Jun 2024 10-Q 05 Mar 2025 2024 Q3
Q1 2024 $39,055,517 $4,024,398 -$3,602,697 -854% 01 Jan 2024 31 Mar 2024 10-Q 05 Mar 2025 2024 Q3
Q4 2023 $35,452,820 $17,938,416 +$15,009,122 +512% 01 Oct 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
Q3 2023 $50,461,942 $21,689,478 -$22,369,880 -3288% 01 Jul 2023 30 Sep 2023 10-Q 05 Mar 2025 2024 Q3
Q2 2023 $28,092,062 $31,280,057 -$28,957,831 -1247% 01 Apr 2023 30 Jun 2023 10-K/A 06 Feb 2025 2023 FY
Q1 2023 $865,769 $421,701 +$1,707,843 +80% 01 Jan 2023 31 Mar 2023 10-Q 28 May 2024 2024 Q1
Q4 2022 $842,074 $2,929,294 01 Oct 2022 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
Q3 2022 $680,402 +$556,623 +450% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $2,322,226 -$2,596,037 -948% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023 2023 Q2
Q1 2022 $2,129,544 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $123,779 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $273,811 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q3 2019 $581 $0 +$2,195 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $1,614 $0 -$2,792 -100% 01 Apr 2019 30 Jun 2019 10-Q 03 Jul 2019 2019 Q2
Q1 2019 $1,178 $0 +$2,792 01 Jan 2019 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $1,614 $581 +$522,418 01 Oct 2018 31 Dec 2018 10-K 05 Mar 2019 2018 FY
Q3 2018 $524,032 $2,195 -$30,119 -108% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
Q2 2018 $493,913 $2,792 -$13,750 -83% 01 Apr 2018 30 Jun 2018 10-Q 03 Jul 2019 2019 Q2
Q1 2018 $480,163 $2,792 -$34,568 -109% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $445,595 $521,837 +$171,678 +25% 01 Oct 2017 31 Dec 2017 10-K 05 Mar 2019 2018 FY
Q3 2017 $617,273 $27,924 -$25,081 -47% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2018 Q3
Q2 2017 $592,192 $16,542 +$41,182 01 Apr 2017 30 Jun 2017 10-K/A 27 Jun 2018 2017 FY
Q1 2017 $633,374 $31,776 +$57,520 01 Jan 2017 31 Mar 2017 10-K/A 27 Jun 2018 2017 FY
Q4 2016 $690,894 $693,515 01 Oct 2016 31 Dec 2016 10-K/A 27 Jun 2018 2017 FY
Q3 2016 $53,005 01 Jul 2016 30 Sep 2016 10-K/A 27 Jun 2018 2017 FY
Q2 2016 $24,640 01 Apr 2016 30 Jun 2016 10-K/A 27 Jun 2018 2017 FY
Q1 2016 $25,744 01 Jan 2016 31 Mar 2016 10-K/A 27 Jun 2018 2017 FY
Q4 2013 $242,623 $263,139 +$1,082,659 +80% 01 Oct 2013 31 Dec 2013 10-K/A 27 Jun 2018 2017 FY
Q3 2013 $1,325,282 $95,487 -$854,656 -113% 01 Jul 2013 30 Sep 2013 10-Q/A 15 May 2014 2013 Q3
Q2 2013 $470,626 $119,219 +$1,030,775 01 Apr 2013 30 Jun 2013 10-Q/A 22 Aug 2013 2013 Q2
Q1 2013 $1,501,401 $3,216 +$30,393 +90% 01 Jan 2013 31 Mar 2013 10-Q/A 15 Aug 2013 2013 Q1
Q4 2012 $1,531,794 $1,345,798 +$14,743,816 +92% 02 Oct 2012 31 Dec 2012 10-K/A 08 May 2014 2012 FY
Q3 2012 $16,275,610 $759,169 +$1,060,034 01 Jul 2012 30 Sep 2012 10-Q/A 15 May 2014 2013 Q3
Q2 2012 $17,335,644 $911,556 -$1,791,561 -204% 01 Apr 2012 30 Jun 2012 10-Q/A 22 Aug 2013 2013 Q2
Q1 2012 $15,544,083 $33,609 01 Jan 2012 31 Mar 2012 10-Q/A 15 Aug 2013 2013 Q1
Q4 2011 $16,089,614 -$17,434,561 -1296% 01 Oct 2011 31 Dec 2011 10-K/A 08 May 2014 2012 FY
Q3 2011 $300,865 +$317,771 +51% 01 Jul 2011 30 Sep 2011 10-Q/A 19 Jul 2013 2011 Q3
Q2 2011 $880,005 +$850,834 +2917% 01 Apr 2011 30 Jun 2011 10-Q/A 18 Jul 2013 2011 Q2
Q4 2010 $1,344,947 01 Oct 2010 31 Dec 2010 10-K/A 31 Mar 2014 2011 FY
Q3 2010 $618,636 01 Jul 2010 30 Sep 2010 10-Q/A 19 Jul 2013 2011 Q3
Q2 2010 $29,171 01 Apr 2010 30 Jun 2010 10-Q/A 18 Jul 2013 2011 Q2

MARIZYME, INC. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $35,452,820 -$34,610,746 -4110% 01 Jan 2023 31 Dec 2023 10-K/A 06 Feb 2025 2023 FY
2022 $842,074 +$1,334,472 +61% 01 Jan 2022 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
2021 $2,176,546 -$2,131,096 -4689% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $45,450 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2018 $1,614 +$443,981 +100% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2019 2018 FY
2017 $445,595 +$245,299 +36% 01 Jan 2017 31 Dec 2017 10-K 05 Mar 2019 2018 FY
2016 $690,894 +$7,166,410 +91% 01 Jan 2016 31 Dec 2016 10-K/A 27 Jun 2018 2017 FY
2015 $7,857,304 +$1,152,170 +13% 01 Jan 2015 31 Dec 2015 10-K/A 27 Jun 2018 2017 FY
2014 $9,009,474 -$8,766,851 -3613% 01 Jan 2014 31 Dec 2014 10-K/A 27 Jun 2018 2017 FY
2013 $242,623 -$541,349 -181% 01 Jan 2013 31 Dec 2013 10-K/A 27 Jun 2018 2017 FY
2012 $298,726 +$16,565,923 01 Jan 2012 31 Dec 2012 10-K/A 27 Jun 2018 2017 FY
2011 $16,267,197 -$18,189,735 -946% 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014 2012 FY
2010 $1,922,538 01 Jan 2010 31 Dec 2010 10-K/A 31 Mar 2014 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.